Vancouver Study Site Begins Screening in Multi-Site Open-Label Extension Study of MDMA-Assisted Therapy for PTSD (MAPPUSX)
On February 28, 2022, the thirteenth study site in our multi-site open-label extension study of MDMA-assisted therapy for PTSD (MAPPUSX) officially began screening potential study participants. This study …